In schizophrenia in particular, perceived benefits of genetic testing are somewhat more guarded. Thirty-five percent of family members, 40% of psychiatric genetic researchers, and 9% of psychiatrists expressed the belief that genetic testing will be used to develop new treatments. Even fewer family members (10%), psychiatric genetic researchers (21%), and psychiatrists (11%) thought genetic testing would allow early detection (DeLisi & Bertisch, 2006).
